[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.240.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Rudd  RA, Seth  P, David  F, Scholl  L.  Increases in drug and opioid-involved overdose deaths—United States, 2010-2015.  MMWR Morb Mortal Wkly Rep. 2016;65(50-51):1445-1452. doi:10.15585/mmwr.mm655051e1PubMedGoogle ScholarCrossref
2.
Scholl  L, Seth  P, Kariisa  M, Wilson  N, Baldwin  G.  Drug and opioid-involved overdose deaths—United States, 2013-2017.  MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419-1427. doi:10.15585/mmwr.mm675152e1PubMedGoogle ScholarCrossref
3.
Jalal  H, Buchanich  JM, Roberts  MS, Balmert  LC, Zhang  K, Burke  DS.  Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016.  Science. 2018;361(6408):eaau1184. doi:10.1126/science.aau1184PubMedGoogle Scholar
4.
Compton  WM, Jones  CM, Baldwin  GT.  Relationship between nonmedical prescription-opioid use and heroin use.  N Engl J Med. 2016;374(2):154-163. doi:10.1056/NEJMra1508490PubMedGoogle ScholarCrossref
5.
Morden  NE, Munson  JC, Colla  CH,  et al.  Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation.  Med Care. 2014;52(9):852-859. doi:10.1097/MLR.0000000000000183PubMedGoogle ScholarCrossref
6.
Shah  A, Hayes  CJ, Martin  BC.  Characteristics of initial prescription episodes and likelihood of long-term opioid use—United States, 2006-2015.  MMWR Morb Mortal Wkly Rep. 2017;66(10):265-269. doi:10.15585/mmwr.mm6610a1PubMedGoogle ScholarCrossref
7.
Barnett  ML, Olenski  AR, Jena  AB.  Opioid-prescribing patterns of emergency physicians and risk of long-term use.  N Engl J Med. 2017;376(7):663-673. doi:10.1056/NEJMsa1610524PubMedGoogle ScholarCrossref
8.
Doctor  JN, Nguyen  A, Lev  R,  et al.  Opioid prescribing decreases after learning of a patient’s fatal overdose.  Science. 2018;361(6402):588-590. doi:10.1126/science.aat4595PubMedGoogle ScholarCrossref
9.
Meara  E, Horwitz  JR, Powell  W,  et al.  State legal restrictions and prescription-opioid use among disabled adults.  N Engl J Med. 2016;375(1):44-53. doi:10.1056/NEJMsa1514387PubMedGoogle ScholarCrossref
10.
Grecu  AM, Dave  DM, Saffer  H.  Mandatory access prescription drug monitoring programs and prescription drug abuse.  J Policy Anal Manage. 2019;38(1):181-209. doi:10.1002/pam.22098PubMedGoogle ScholarCrossref
11.
Barnett  ML, Gray  J, Zink  A, Jena  AB.  Coupling policymaking with evaluation—the case of the opioid crisis.  N Engl J Med. 2017;377(24):2306-2309. doi:10.1056/NEJMp1710014PubMedGoogle ScholarCrossref
12.
SUPPORT for Patients and Communities Act, HR 6, 115th Cong, (2018).
13.
Dasgupta  N, Beletsky  L, Ciccarone  D.  Opioid crisis: no easy fix to its social and economic determinants.  Am J Public Health. 2018;108(2):182-186. doi:10.2105/AJPH.2017.304187PubMedGoogle ScholarCrossref
14.
Quinones  S.  Dreamland: The True Tale of America’s Opioid Epidemic. New York, NY: Bloomsbury; 2015.
15.
Case  A, Deaton  A.  Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century.  Proc Natl Acad Sci U S A. 2015;112(49):15078-15083. doi:10.1073/pnas.1518393112PubMedGoogle ScholarCrossref
16.
Case  A, Deaton  A.  Mortality and morbidity in the 21st century.  Brookings Pap Econ Act. 2017;2017(Spring):397-476. doi:10.1353/eca.2017.0005PubMedGoogle ScholarCrossref
17.
Currie  J, Jin  JY, Schnell  MUSUS. employment and opioids: is there a connection? NBER Working Paper No. 24440. https://www.nber.org/papers/w24440. Revised April 2019. Accessed November 11, 2019.
18.
Ruhm  CJ.  Drivers of the fatal drug epidemic.  J Health Econ. 2019;64:25-42. doi:10.1016/j.jhealeco.2019.01.001PubMedGoogle ScholarCrossref
19.
Hollingsworth  A, Ruhm  CJ, Simon  K.  Macroeconomic conditions and opioid abuse.  J Health Econ. 2017;56:222-233. doi:10.1016/j.jhealeco.2017.07.009PubMedGoogle ScholarCrossref
20.
Carpenter  CS, McClellan  CB, Rees  DI.  Economic conditions, illicit drug use, and substance use disorders in the United States.  J Health Econ. 2017;52:63-73. doi:10.1016/j.jhealeco.2016.12.009PubMedGoogle ScholarCrossref
21.
O’Brien  RL, Venkataramani  AS, Tsai  AC.  Economic mobility and the mortality crisis among US middle-aged whites.  Epidemiology. 2017;28(2):e12-e13. doi:10.1097/EDE.0000000000000585PubMedGoogle ScholarCrossref
22.
Venkataramani  AS, Chatterjee  P, Kawachi  I, Tsai  AC.  Economic opportunity, health behaviors, and mortality in the United States.  Am J Public Health. 2016;106(3):478-484. doi:10.2105/AJPH.2015.302941PubMedGoogle ScholarCrossref
23.
Autor  D, Dorn  D, Hanson  G.  When work disappears: manufacturing decline and the falling marriage market value of young men.  Am Econ Rev. 2019;2(1):161-178. doi:10.1257/aeri.20180010Google Scholar
24.
Pierce  JR, Schott  PK.  Trade liberalization and mortality: evidence from US counties.  Am Econ Rev. In press. https://www.aeaweb.org/articles?id=10.1257/aeri.20180396. Accessed November 25, 2019.Google Scholar
25.
Dean  A, Kimmel  S.  Free trade and opioid overdose death in the United States.  SSM Popul Health. 2019;8:100409. doi:10.1016/j.ssmph.2019.100409PubMedGoogle Scholar
26.
Goldstein  A.  Janesville: An American Story. New York, NY: Simon & Schuster; 2017.
27.
Rubenstein  JM. The evolving geography of production—is manufacturing activity moving out of the Midwest? evidence from the auto industry. Federal Reserve Bank of Chicago working paper No. SP-3. https://ideas.repec.org/p/fip/fedhas/sp-3.html. Published 1996. Accessed November 11, 2019.
28.
Ramey  V, Vine  D, Bresnahan  TF.  Weekly Production Scheduling at Assembly Plants in the United States Automobile Industry: 1972-1983 and 1990-2001. Ann Arbor, MI: Inter-university Consortium for Political and Social Research; 2009.
29.
Platzer  MD, Harrison  GJ.  The U.S. Automotive Industry: National and State Trends in Manufacturing Employment. Washington, DC: Congressional Research Service; 2009.
30.
Chetty  R, Stepner  M, Abraham  S,  et al.  The association between income and life expectancy in the United States, 2001-2014.  JAMA. 2016;315(16):1750-1766. doi:10.1001/jama.2016.4226PubMedGoogle ScholarCrossref
31.
Chetty  R, Hendren  N, Kline  P, Saez  E.  Where is the land of opportunity? the geography of intergenerational mobility in the United States.  Q J Econ. 2014;129(4):1553-1623. doi:10.1093/qje/qju022Google ScholarCrossref
32.
Ramaswamy  S, Manyika  J, Pinkus  G,  et al.  Making it in America: Revitalizing US Manufacturing. New York, NY: McKinsey & Co Global Institute; 2017.
33.
Nunn  R, Parsons  J, Shambaugh  J. The Geography of Prosperity. In: Nunn  R, Shambaugh  J, eds.  Place-Based Policies for Shared Economic Growth. Washington, DC: Brookings Institution; 2018.
34.
Currie  J, Schwandt  H.  Mortality inequality: the good news from a county-level approach.  J Econ Perspect. 2016;30(2):29-52. doi:10.1257/jep.30.2.29PubMedGoogle ScholarCrossref
35.
National Center for Health Statistics, Centers for Disease Control and Prevention. Data release policy for vital statistics micro-data files. https://www.cdc.gov/nchs/nvss/dvs_data_release.htm. Accessed February 14, 2019.
36.
National Center for Health Statistics, Centers for Disease Control and Prevention. U.S. Census populations with bridged race categories. https://www.cdc.gov/nchs/nvss/bridged_race.htm. Accessed February 14, 2019.
37.
Ruhm  CJ.  Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999-2015.  Addiction. 2018;113(7):1339-1344. doi:10.1111/add.14144PubMedGoogle ScholarCrossref
38.
Warner  M, Paulozzi  LJ, Nolte  KB, David  GG, Nelson  LS.  State variation in certifying manner of death and drugs involved in drug intoxication deaths.  Acad Forensic Pathol. 2013;3(2):231-237. doi:10.23907/2013.029Google ScholarCrossref
39.
Centers for Disease Control and Prevention.  Prescription Drug Overdose Data & Statistics: Guide to ICD-9-CM and ICD-10 Codes Related to Poisoning and Pain. Atlanta, GA: Centers for Disease Control and Prevention; 2013.
40.
Jacobson  LS, LaLonde  RJ, Sullivan  DG.  Earnings losses of displaced workers.  Am Econ Rev. 1993;83(4):685-709.Google Scholar
41.
Sullivan  D, von Wachter  T.  Job displacement and mortality: an analysis using administrative data.  Q J Econ. 2009;124(3):1265-1306. doi:10.1162/qjec.2009.124.3.1265Google ScholarCrossref
42.
Goodman-Bacon  A. Difference-in-differences with variation in treatment timing. NBER Working Paper No. 25018. https://www.nber.org/papers/w25018. Accessed November 11, 2019.
43.
Shrier  I, Platt  RW.  Reducing bias through directed acyclic graphs.  BMC Med Res Methodol. 2008;8:70. doi:10.1186/1471-2288-8-70PubMedGoogle ScholarCrossref
44.
Angrist  JD, Pischke  J-S.  Mastering Metrics: The Path From Cause to Effect. Princeton, NJ: Princeton University Press; 2015.
45.
Bertrand  M, Dulfo  E, Mullainathan  S.  How much should we trust differences-in-differences estimates?  Q J Econ. 2004;119(1):249-275. doi:10.1162/003355304772839588Google ScholarCrossref
46.
Sommers  BD.  State Medicaid expansions and mortality, revisited: a cost-benefit analysis.  Am J Health Econ. 2017;3(3):392-421. doi:10.1162/ajhe_a_00080Google ScholarCrossref
47.
Meara  ER, Richards  S, Cutler  DM.  The gap gets bigger: changes in mortality and life expectancy, by education, 1981-2000.  Health Aff (Millwood). 2008;27(2):350-360. doi:10.1377/hlthaff.27.2.350PubMedGoogle ScholarCrossref
48.
Novosad  P, Rafkin  C.  Mortality Change Among Less Educated Americans. Mimeo. http://www.dartmouth.edu/~novosad/novosad-rafkin-mortality.pdf. Published April 2019. Accessed November 19, 2019.
49.
Muennig  PA, Reynolds  M, Fink  DS, Zafari  Z, Geronimus  AT.  America’s declining well-being, health, and life expectancy: not just a white problem.  Am J Public Health. 2018;108(12):1626-1631. doi:10.2105/AJPH.2018.304585PubMedGoogle ScholarCrossref
50.
Kiang  MV, Basu  S, Chen  J, Alexander  MJ.  Assessment of changes in the geographical distribution of opioid-related mortality across the United States by opioid type, 1999-2016.  JAMA Netw Open. 2019;2(2):e190040. doi:10.1001/jamanetworkopen.2019.0040PubMedGoogle Scholar
51.
Dwyer-Lindgren  L, Bertozzi-Villa  A, Stubbs  RW,  et al.  Trends and patterns of geographic variation in mortality from substance use disorders and intentional injuries among US counties, 1980-2014.  JAMA. 2018;319(10):1013-1023. doi:10.1001/jama.2018.0900PubMedGoogle ScholarCrossref
52.
Auerbach  J, Miller  BF.  Deaths of despair and building a national resilience strategy.  J Public Health Manag Pract. 2018;24(4):297-300. doi:10.1097/PHH.0000000000000835PubMedGoogle ScholarCrossref
53.
Metzl  JM, Hansen  H.  Structural competency: theorizing a new medical engagement with stigma and inequality.  Soc Sci Med. 2014;103:126-133. doi:10.1016/j.socscimed.2013.06.032PubMedGoogle ScholarCrossref
54.
Singh  P.  Dying and Living in the Neighborhood. Baltimore, MD: Johns Hopkins University Press; 2016.
55.
Alley  DE, Asomugha  CN, Conway  PH, Sanghavi  DM.  Accountable health communities—addressing social needs through Medicare and Medicaid.  N Engl J Med. 2016;374(1):8-11. doi:10.1056/NEJMp1512532PubMedGoogle ScholarCrossref
56.
Muro  M, Maxim  R, Whiton  J.  Automation and Artificial Intelligence: How Machines are Affecting People and Places. Washington, DC: Brookings Institution; 2019.
57.
Shah  NS, Lloyd-Jones  DM, O’Flaherty  M,  et al.  Trends in cardiometabolic mortality in the United states, 1999-2017.  JAMA. 2019;322(8):780-782. doi:10.1001/jama.2019.9161PubMedGoogle ScholarCrossref
58.
Brand  JE.  The far-reaching impact of job loss and unemployment.  Annu Rev Sociol. 2015;41:359-375. doi:10.1146/annurev-soc-071913-043237PubMedGoogle ScholarCrossref
59.
Cherlin  A.  Labor’s Love Lost: The Rise and Fall of the Working-Class Family in America. New York, NY: Russell Sage Foundation; 2014.
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    Dosages
    Scott Wierson, BSEE | Research and Expert Witness
    What were the estimated average dosage levels used by the victims for each type of drug?
    CONFLICT OF INTEREST: None Reported
    Views 20,184
    Citations 0
    Original Investigation
    December 30, 2019

    Association Between Automotive Assembly Plant Closures and Opioid Overdose Mortality in the United States: A Difference-in-Differences Analysis

    Author Affiliations
    • 1Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia
    • 2Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia
    • 3Department of Sociology, Yale University, New Haven, Connecticut
    • 4Center for Global Health, Massachusetts General Hospital, Boston
    • 5Harvard Medical School, Boston, Massachusetts
    JAMA Intern Med. Published online December 30, 2019. doi:10.1001/jamainternmed.2019.5686
    Key Points

    Question  Are closures of US automobile assembly plants associated with increases in opioid overdose mortality rates among working-age adults?

    Findings  In this difference-in-differences study, US manufacturing counties that experienced an automotive assembly plant closure were compared with counties in which automotive plants remained open from 1999 to 2016. Automotive assembly plant closures were associated with a statistically significant increase in county-level opioid overdose mortality rates among adults aged 18 to 65 years.

    Meaning  Automotive assembly plant closures were associated with increases in opioid overdose mortality, highlighting the potential importance of the role of declining economic opportunity in the US opioid overdose crisis.

    Abstract

    Importance  Fading economic opportunity has been hypothesized to be an important factor associated with the US opioid overdose crisis. Automotive assembly plant closures are culturally significant events that substantially erode local economic opportunities.

    Objective  To estimate the extent to which automotive assembly plant closures were associated with increasing opioid overdose mortality rates among working-age adults.

    Design, Setting, and Participants  A county-level difference-in-differences study was conducted among adults aged 18 to 65 years in 112 manufacturing counties located in 30 commuting zones (primarily in the US South and Midwest) with at least 1 operational automotive assembly plant as of 1999. The study analyzed county-level changes from January 1, 1999, to December 31, 2016, in age-adjusted, county-level opioid overdose mortality rates before vs after automotive assembly plant closures in manufacturing counties affected by plant closures compared with changes in manufacturing counties unaffected by plant closures. Data analyses were performed between April 1, 2018, and July 20, 2019.

    Exposure  Closure of automotive assembly plants in the commuting zone of residence.

    Main Outcomes and Measures  The primary outcome was the county-level age-adjusted opioid overdose mortality rate. Secondary outcomes included the overall drug overdose mortality rate and prescription vs illicit drug overdose mortality rates.

    Results  During the study period, 29 manufacturing counties in 10 commuting zones were exposed to an automotive assembly plant closure, while 83 manufacturing counties in 20 commuting zones remained unexposed. Mean (SD) baseline opioid overdose rates per 100 000 were similar in exposed (0.9 [1.4]) and unexposed (1.0 [2.1]) counties. Automotive assembly plant closures were associated with statistically significant increases in opioid overdose mortality. Five years after a plant closure, mortality rates had increased by 8.6 opioid overdose deaths per 100 000 individuals (95% CI, 2.6-14.6; P = .006) in exposed counties compared with unexposed counties, an 85% increase relative to the mortality rate of 12 deaths per 100 000 observed in unexposed counties at the same time point. In analyses stratified by age, sex, and race/ethnicity, the largest increases in opioid overdose mortality were observed among non-Hispanic white men aged 18 to 34 years (20.1 deaths per 100 000; 95% CI, 8.8-31.3; P = .001) and aged 35 to 65 years (12.8 deaths per 100 000; 95% CI, 5.7-20.0; P = .001). We observed similar patterns of prescription vs illicit drug overdose mortality. Estimates for opioid overdose mortality in nonmanufacturing counties were not statistically significant.

    Conclusions and Relevance  From 1999 to 2016, automotive assembly plant closures were associated with increases in opioid overdose mortality. These findings highlight the potential importance of eroding economic opportunity as a factor in the US opioid overdose crisis.

    ×